Human trials are set to commence after a potential cancer vaccine was shown to eliminate all traces of tumors in mice. » RELATED: Breast cancer treatment may trigger heart problems, study says ...

Oct. 23, 2021 — A pharmaceutical product called TT-10, which spurs proliferation of heart muscle cells, was thought to offer promise to treat heart attacks. In a mouse heart-attack model several ...

CAR-T cell therapy, an immune-based therapy that has had notable success in treating difficult cancers, could soon fight one of the most common human ailments—tissue fibrosis (Nature 2019, DOI ...

A new microchip could help scientists uncover secrets of heart regeneration in baby mice. Baby mice might be small, but they're tough, too. For their first seven days of life, they have the ...

An injectable polymer therapy that takes advantage of the excess of cysteines on tumor cells can stimulate an immune response to fight many different types of cancers in mice (ACS Cent. Sci. 2022 ...

When testing this hypothesis on mice models, researchers discovered that the combination of all three mutations created a highly aggressive cancer, which contradicted the initial hypothesis.

A hormone secreted by fat cells can restrain the growth of liver tumors in mice, according to a new study from the University of Michigan Life Sciences Institute. The findings offer a proof-of ...

In fact, more than 50% of mice treated with the mutated T cells had undetectable signs of tumor. The team did a parallel analysis to further analyze how the mutations in CD3ζ influence tumor burden.

In three different mouse models of ER+ breast cancers, the researchers found that a single dose of ErSO-TFPy was enough to either nearly or completely eradicate tumors across a whole range of sizes.

In preclinical tests in mice, treatment using the fully modified, tumor-targeting miR-34a halted tumor growth for the 21-day evaluation period, and resulted in complete cures in some animals.

A hormone secreted by fat cells can restrain the growth of liver tumors in mice, according to a new study from the University of Michigan Life Sciences Institute.